These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21198274)

  • 61. Chromogranin A levels in chronic liver disease and hepatocellular carcinoma.
    Massironi S; Fraquelli M; Paggi S; Sangiovanni A; Conte D; Sciola V; Ciafardini C; Colombo M; Peracchi M
    Dig Liver Dis; 2009 Jan; 41(1):31-5. PubMed ID: 18762462
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
    Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
    World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Elevated serum level of thioredoxin in patients with hepatocellular carcinoma.
    Miyazaki K; Noda N; Okada S; Hagiwara Y; Miyata M; Sakurabayashi I; Yamaguchi N; Sugimura T; Terada M; Wakasugi H
    Biotherapy; 1998; 11(4):277-88. PubMed ID: 9950104
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients.
    Carr BI; Guerra V
    Int J Biol Markers; 2017 Oct; 32(4):e391-e396. PubMed ID: 28862714
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
    Hwang SJ; Luo JC; Li CP; Chu CW; Wu JC; Lai CR; Chiang JH; Chau GY; Lui WY; Lee CC; Chang FY; Lee SD
    World J Gastroenterol; 2004 Sep; 10(17):2472-7. PubMed ID: 15300887
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Marked hypophosphatemia with decreased serum 1,25-dihydroxyvitamin D in a patient with hepatocellular carcinoma complicating liver cirrhosis.
    Mizuno Y; Masaki N; Hashimoto H; Ogata I; Aizawa C; Fujiwara K; Toda G; Mori M; Machinami R; Kurokawa K
    Jpn J Med; 1991; 30(1):81-6. PubMed ID: 1713978
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detection of circulating intercellular adhesion molecule-1 in hepatocellular carcinoma.
    Hyodo I; Jinno K; Tanimizu M; Hosokawa Y; Nishikawa Y; Akiyama M; Mandai K; Moriwaki S
    Int J Cancer; 1993 Nov; 55(5):775-9. PubMed ID: 7503959
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical evaluation of tissue plasminogen activator (t-PA) levels in patients with liver diseases.
    Okabe K; Kato I; Sato S; Kashiwabara T; Furuta S; Sato H; Tanikawa K; Kumashiro R; Kanayama M
    Gastroenterol Jpn; 1992 Feb; 27(1):61-8. PubMed ID: 1313384
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease.
    Gray J; Chattopadhyay D; Beale GS; Patman GL; Miele L; King BP; Stewart S; Hudson M; Day CP; Manas DM; Reeves HL
    BMC Cancer; 2009 Aug; 9():271. PubMed ID: 19656391
    [TBL] [Abstract][Full Text] [Related]  

  • 71. alpha-Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis.
    Chayvialle JA; Brissot P; Pelletier MJ; Hita de Nercy Y; Lambert R; Bourel M
    Digestion; 1977; 16(1-2):118-27. PubMed ID: 79512
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A study of serological markers and lipid profile in non-alcoholic liver cirrhosis patients.
    Khan S; Jamal S
    Pak J Pharm Sci; 2018 Jan; 31(1):89-93. PubMed ID: 29348089
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma.
    Soresi M; Cervello M; Lipani G; Carroccio A; Cartabellotta A; Marasà L; Casto C; Virruso L; Montalto G
    Eur J Gastroenterol Hepatol; 1997 Aug; 9(8):805-9. PubMed ID: 9282280
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients.
    Feder S; Haberl EM; Spirk M; Weiss TS; Wiest R; Buechler C
    Clin Exp Med; 2020 May; 20(2):289-297. PubMed ID: 32078718
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response.
    El-Emshaty HM; Nasif WA; Mohamed IE
    Dis Markers; 2015; 2015():707254. PubMed ID: 26783377
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
    Cervello M; Virruso L; Lipani G; Giannitrapani L; Soresi M; Carroccio A; Gambino R; Sanfililippo R; Marasà L; Montalto G
    J Cancer Res Clin Oncol; 2000 Jun; 126(6):345-51. PubMed ID: 10870645
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis.
    Zhang D; Huang J; Luo D; Feng X; Liu Y; Liu Y
    Biomark Med; 2017 May; 11(5):423-430. PubMed ID: 28621608
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Heterogeneity of alpha-fetoprotein with concanavalin A-binding properties in the serum and ascites of liver neoplasms and liver cirrhosis].
    Fujise K; Nagamori S; Hasumura S; Homma S; Sujino H; Kameda H
    Nihon Shokakibyo Gakkai Zasshi; 1983 Nov; 80(11):2363-8. PubMed ID: 6200631
    [No Abstract]   [Full Text] [Related]  

  • 79. Increased serum granulocyte colony stimulating factor in Turkish hepatocellular carcinoma patients.
    Kaya AO; Coskun U; Sancak B; Buyukberber S; Yildiz R; Gulbahar O; Benekli M; Ozenirler S
    Asian Pac J Cancer Prev; 2009; 10(3):403-6. PubMed ID: 19640182
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A case of hepatocellular carcinoma with marked hyperfibrinogenemia.
    Amemiya N; Yatomi Y; Endo T; Mizoe A; Yoda-Endo M; Yuminamochi T; Yamamoto M; Matsumoto Y; Ozaki Y; Kume S
    Acta Haematol; 1997; 97(4):236-8. PubMed ID: 9158669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.